P8813
普罗替林 盐酸盐
≥99% (TLC), powder
别名:
N-Methyl-5H-dibenzo[a,d]cycloheptene-5-propanamine hydrochloride
登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式（希尔记法）:
C19H21N · HCl
化学文摘社编号:
分子量:
299.84
NACRES:
NA.77
PubChem Substance ID:
UNSPSC Code:
12352200
EC Number:
214-956-3
MDL number:
InChI key
OGQDIIKRQRZXJH-UHFFFAOYSA-N
InChI
1S/C19H21N.ClH/c1-20-14-6-11-19-17-9-4-2-7-15(17)12-13-16-8-3-5-10-18(16)19;/h2-5,7-10,12-13,19-20H,6,11,14H2,1H3;1H
SMILES string
Cl[H].CNCCCC1c2ccccc2C=Cc3ccccc13
assay
≥99% (TLC)
form
powder
color
white to off-white
solubility
H2O: 50 mg/mL
Gene Information
human ... SLC6A2(6530), SLC6A4(6532)
正在寻找类似产品? 访问 产品对比指南
Biochem/physiol Actions
Norepinephrine uptake blocker.
Features and Benefits
This compound is featured on the Biogenic Amine Transporters page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.
Disclaimer
Shelf-life of the powder is at least three years at room temperature.
signalword
Danger
Hazard Classifications
Acute Tox. 3 Oral - Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
target_organs
Respiratory system
存储类别
6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
wgk
WGK 3
ppe
dust mask type N95 (US), Eyeshields, Faceshields, Gloves
M M Makhay et al.
Pharmacology, biochemistry, and behavior, 63(2), 319-324 (1999-06-17)
The ability of indirectly acting agonists such as norepinephrine uptake inhibitors, serotonin reuptake inhibitors, and atypical antidepressants to substitute for clenbuterol, a beta-2 adrenergic agonist, was examined in rats trained to discriminate 0.03 mg/kg clenbuterol and saline using a fixed-ratio
P Lévy et al.
Sleep, 19(9 Suppl), S101-S110 (1996-11-01)
The spectrum of respiratory sleep disorders has been extended in the last years to include conditions that are less well defined than severe obstructive sleep apnea (OSA). Moderate OSA, snoring, and upper airway resistance syndrome (UARS) represent three conditions in
Anticholinergic delirium possibly associated with protriptyline and fluoxetine.
K L Paul et al.
The Annals of pharmacotherapy, 31(10), 1260-1261 (1997-10-24)
[Treatment of sleep apnea-hypoapnea syndrome].
J M Montserrat et al.
Archivos de bronconeumologia, 34(4), 204-206 (1998-06-05)
O F D'Cruz et al.
Neurology, 44(11), 2189-2191 (1994-11-01)
Cataplexy is a cardinal manifestation of the narcolepsy syndrome. Although symptomatic narcolepsy is well described, isolated cataplexy is extremely rare. We reviewed clinical and radiologic data in two patients with isolated symptomatic cataplexy and associated CNS disease. In an HLA-DR2-positive
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持